Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease

Judith Wellens, Matthew Edmans, Uri Obolski, Colleen GC McGregor, Peter Simmonds, Marc Turner, Lisa Jarvis, Donal Skelley, Susanna Dunachie, Eleanor Barnes, David W Eyre, Jean-Frederic Colombel, Serre-Yu Wong, Paul Klenerman, James O Lindsey, Jack Satsangi, Craig P Thompson
doi: https://doi.org/10.1101/2021.10.13.21264916

Article Information

doi 
https://doi.org/10.1101/2021.10.13.21264916
History 
  • October 18, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Judith Wellens1,2,*,
  2. Matthew Edmans1,3,*,
  3. Uri Obolski4,5,
  4. Colleen GC McGregor1,
  5. Peter Simmonds3,
  6. Marc Turner6,
  7. Lisa Jarvis6,
  8. Donal Skelley3,
  9. Susanna Dunachie9,10,11,
  10. Eleanor Barnes1,3,
  11. David W Eyre9,12,
  12. Jean-Frederic Colombel14,
  13. Serre-Yu Wong14,
  14. Paul Klenerman1,3,
  15. James O Lindsey15,
  16. Jack Satsangi1 and
  17. Craig P Thompson16,†
  1. 1Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford
  2. 2Translational Research for Gastrointestinal Diseases, University hospitals Leuven, Herestraat, Leuven, Belgium
  3. 3Nuffield Department of Medicine, University of Oxford, Oxford, UK
  4. 4School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  5. 5Porter School of Environmental and Earth Sciences, Faculty of Exact Sciences, Tel-Aviv University, TelAviv, Israel
  6. 6National Microbiology Reference Unit, Scottish National Blood Transfusion Service, Edinburgh, UK
  7. 7Nuffield Department of Clinical Neurosciences, University of Oxford, UK
  8. 8Oxford University Hospitals NHS Foundation Trust, UK
  9. 9Department of Microbiology/Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
  10. 10Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK
  11. 11Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
  12. 12Nuffield Department of Population Health, University of Oxford, Oxford, UK
  13. 13Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  14. 14Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  15. 15Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK
  16. 16Department of Biology, University of Oxford, Oxford, UK
  1. ↵† Corresponding author; email: craigpeterthompson{at}gmail.com

  1. ↵* contributed equally.

Back to top
Posted October 18, 2021.
Download PDF
Data/Code
Email
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Judith Wellens, Matthew Edmans, Uri Obolski, Colleen GC McGregor, Peter Simmonds, Marc Turner, Lisa Jarvis, Donal Skelley, Susanna Dunachie, Eleanor Barnes, David W Eyre, Jean-Frederic Colombel, Serre-Yu Wong, Paul Klenerman, James O Lindsey, Jack Satsangi, Craig P Thompson
medRxiv 2021.10.13.21264916; doi: https://doi.org/10.1101/2021.10.13.21264916
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area